Quality of Life After Wide Surgical Excision in Patients With Hidradenitis Suppurativa

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-03-15

Study Completion Date

2017-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients undergoing wide surgical excision of their hidradenitis suppurativa areas are asked by telephone about their quality of life by standard questionnaires (WHOQOL-BREF, DLQI, Skindex, MHF, FLQA-d) and their sexual function (FSFI, IIEF).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hidradenitis Suppurativa Wide Excision

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Hidradenitis suppurativa Wide excision Quality of Life Sexual Function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hidradenitis suppurativa that was wide excised in 2013 in Fachklinik Hornheide
* Agreed to retrospective analysis and questionnaires

Exclusion Criteria

* Non-compliance

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tobias Kisch

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tobias Kisch, MD

Role: STUDY_DIRECTOR

University of Schleswig-Holstein, Campus Lübeck, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Schleswig-Holstein

Lübeck, Schleswig-Holstein, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1176-0162

Identifier Type: OTHER

Identifier Source: secondary_id

14-015

Identifier Type: -

Identifier Source: org_study_id